Since pH-related cancer growth and metastasis might be dependent on the enzyme activity of the CA IX isoform, the identification of CA IX as tumour biomarker in the liquid biopsy is crucial for a new approach concerning the treatment of malignancy. This evidence concerns the gene CA9 and cancer.